Muntendam Pieter 4
4 · BG Medicine, Inc. · Filed Jun 1, 2012
Insider Transaction Report
Form 4
Muntendam Pieter
DirectorPresident, CEO
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2012-05-30−100,000→ 82,239 totalExercise: $0.90Exp: 2014-12-16→ Common Stock (100,000 underlying) - Exercise/Conversion
Common Stock
2012-05-30$0.90/sh+100,000$90,000→ 112,469 total
Footnotes (1)
- [F1]All shares underlying this option have vested and the reporting person partially exercised the option by paying cash.